BioSpace News Archive

Nevro Corp., a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, announced that its Board of Directors has appointed Karen N. Prange as a member of the Board.

Ribon Therapeutics, a clinical stage biotechnology company developing first-in-class therapeutics targeting novel enzyme families activated under cellular stress conditions, today announced the appointment of Neal Rosen, M.D., Ph.D., to its scientific advisory board (SAB).

Castle Biosciences, Inc. (Nasdaq: CSTL) today announced that the Company was recently added to the NASDAQ Biotechnology Index (Nasdaq: NBI), effective prior to the market open on Monday, December 23, 2019.

Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP, OTCQB:ASPCF) today announced that it has closed the previously announced amendment and restatement of the US$5.0 million subordinated secured term loan facility previously entered into on July 19, 2019 between Acerus and First Generation Capital, Inc.

Epizyme, Inc., a late-stage biopharmaceutical company developing novel epigenetic therapies, announced that trading of its common stock has been halted.

To combat child hunger in Utah, on Dec. 19 USANA Health Sciences, a global health and wellness leader, will open Utah’s newest food-packing facility.

Data published in Diabetes, Obesity and Metabolism demonstrate that Qsymia provides statistically significant weight loss compared with placebo over an 8 week period, provide basis for ongoing 56 week phase 4 study in obese adolescents

BridgeBio Pharma, Inc. and Medison Pharma Ltd. have entered into an exclusive license agreement under which Medison received rights from Origin to distribute, market, sell and otherwise commercialize Origin’s drug product known as fosdenopterin in Israel..

Kleo Pharmaceuticals, Inc. announced that its Chief Executive Officer Doug Manion, MD, will present at Biotech Showcase 2020, to be held January 13-15, 2020 at the Hilton San Francisco Union Square in San Francisco.

Danaher Corporation announced the final results of its previously announced offer to holders of shares of Danaher common stock to exchange their shares of Danaher common stock for shares of common stock of Envista Holdings Corporation owned by Danaher.